Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-16-007907
Filing Date
2016-08-11
Accepted
2016-08-11 13:22:32
Documents
52
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q tlog-20160630x10q.htm 10-Q 1375437
2 EX-10.1 tlog-20160630ex1016bc4d6.htm EX-10.1 75842
3 EX-31.1 tlog-20160630ex311b3560c.htm EX-31.1 18284
4 EX-31.2 tlog-20160630ex312b5dda5.htm EX-31.2 18326
5 EX-32.1 tlog-20160630ex3211fe4c6.htm EX-32.1 7745
6 EX-32.2 tlog-20160630ex322a08473.htm EX-32.2 7567
  Complete submission text file 0001558370-16-007907.txt   6270234

Data Files

Seq Description Document Type Size
7 EX-101.INS tlog-20160630.xml EX-101.INS 1509578
8 EX-101.SCH tlog-20160630.xsd EX-101.SCH 36417
9 EX-101.CAL tlog-20160630_cal.xml EX-101.CAL 46176
10 EX-101.DEF tlog-20160630_def.xml EX-101.DEF 150624
11 EX-101.LAB tlog-20160630_lab.xml EX-101.LAB 413480
12 EX-101.PRE tlog-20160630_pre.xml EX-101.PRE 273999
Mailing Address 343 PHOENIXVILLE PIKE MALVERN PA 19355
Business Address 343 PHOENIXVILLE PIKE MALVERN PA 19355 610-889-9900
TETRALOGIC PHARMACEUTICALS CORP (Filer) CIK: 0001361248 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36208 | Film No.: 161823890
SIC: 2834 Pharmaceutical Preparations